Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HES1 is a protein-coding gene that encodes a basic helix-loop-helix (bHLH) transcription factor. It acts primarily as a transcriptional repressor, regulating the expression of genes that require bHLH proteins for their activation. HES1 plays critical roles in embryonic development by influencing cell proliferation and differentiation. It maintains stem cells and progenitor cells in an undifferentiated state across multiple tissues—especially within the nervous system and digestive organs—by repressing proneural or pro-differentiation genes. A key mediator within the Notch signaling pathway, HES1 transduces signals that maintain progenitor pools during organogenesis. Mutations or dysregulation of HES1 have been linked to several diseases including Alagille Syndrome 1—a disorder affecting liver function—and developmental abnormalities such as Strawberry Gallbladder.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hes family bHLH transcription factor 1 (HES1).